Event Date/Time: Feb 05, 2012
End Date/Time: Feb 10, 2012
Feb 05, 2012
Early Registration Date:
Dec 05, 2011
Nearly five years ago, a new type of T cell, called the Th17 cell, was discovered. Th17 cells have unique regulation and have been shown to be associated with many types of immune diseases and cancer. Since the first Keystone Symposia meeting on Th17 cells in 2009, there has been rapid progress in our understanding of the roles of IL-17-producing T cells in innate immunity to infection, the plasticity of Th17 cell, and genetic diseases associated with Th17 defects. The goal of this second Keystone Symposia meeting on Th17 cells is to gather experts in basic and clinical research areas and provide a productively interactive forum to further our understanding of Th17 regulation and function in immune responses and diseases. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on The Biology of Cytokines, which will share a keynote address and two plenary sessions with this meeting.
This meeting is held jointly with the Keystone Symposia meeting "The Biology of Cytokines."
Registering for one meeting in a set of joint meetings enables participation in sessions of the other, pending space availability.
Abstract & scholarship - October 5, 2011
Late-breaking abstract - November 7, 2011